Researchers studied nearly 9,000 people to understand why some adults lose muscle mass as they age—a condition called sarcopenia. They found that a simple blood test measuring the ratio between two types of cells and cholesterol might help doctors identify who’s at risk. When this ratio was higher, people were more likely to have weak muscles. This discovery could help doctors catch muscle loss earlier and help people stay stronger longer, though more research is needed to confirm these findings.

The Quick Take

  • What they studied: Whether a simple blood test measuring the balance between infection-fighting cells and good cholesterol could predict who might develop weak muscles and muscle loss.
  • Who participated: 9,040 adults from a large U.S. health survey conducted between 2011 and 2018. About 721 of these people had sarcopenia (significant muscle loss).
  • Key finding: People with higher ratios of infection-fighting cells to good cholesterol were 16% more likely to have muscle loss. This relationship wasn’t perfectly straight—it got stronger at certain levels.
  • What it means for you: A routine blood test might someday help your doctor predict muscle loss risk before it becomes serious. However, this is early research, and doctors aren’t yet using this test clinically. Talk to your healthcare provider about maintaining muscle strength through exercise and proper nutrition.

The Research Details

Researchers looked at health information already collected from thousands of Americans between 2011 and 2018. They compared blood test results from people with muscle loss to those without it. This type of study is called ‘cross-sectional’ because it takes a snapshot in time rather than following people over years.

The researchers measured something called the neutrophil-to-HDL ratio. Neutrophils are white blood cells that fight infections, and HDL is the ‘good’ cholesterol that protects your heart. They used statistical tools to see if higher ratios predicted muscle loss, even after accounting for other factors like age, weight, and other health conditions.

They also tested whether this relationship worked differently for men versus women, different racial groups, and people with high cholesterol. This helped them understand if the blood test would be equally useful for everyone.

Finding a simple, inexpensive blood test that predicts muscle loss is important because sarcopenia (age-related muscle loss) affects millions of older adults and increases fall risk, disability, and loss of independence. If doctors could identify at-risk people early, they could recommend strength training and good nutrition before serious problems develop. This study suggests a routine blood test might help with that early detection.

This study used data from a well-respected national health survey, which is a strength. The large sample size (over 9,000 people) makes the findings more reliable. However, because it’s a snapshot in time rather than following people forward, we can’t be completely sure the blood test causes muscle loss—only that they’re connected. The researchers did several checks to make sure their results were solid, which is good scientific practice.

What the Results Show

The main finding was clear: people with higher neutrophil-to-HDL ratios were significantly more likely to have sarcopenia. For every one-unit increase in this ratio, the odds of having muscle loss went up by 16%. This relationship was statistically very strong (meaning it’s unlikely to be due to chance).

Interestingly, the relationship wasn’t perfectly linear—meaning it didn’t increase at the same rate across all levels. At certain higher levels of the ratio, the risk jumped more dramatically. This suggests there might be a threshold where muscle loss risk really increases.

When researchers looked at different groups of people, they found the relationship was stronger in some groups than others. Women, certain racial groups, and people with high cholesterol showed stronger connections between the blood test ratio and muscle loss. This suggests the test might work better for predicting risk in some populations.

The study found that sex, race, and whether someone had high cholesterol all affected how well this blood test predicted muscle loss. This is important because it means a one-size-fits-all approach might not work—doctors might need to interpret the test differently depending on who the patient is. The researchers also tested their findings in people aged 40 and older to make sure their results held up, which they did.

This research adds to growing evidence that inflammation markers (like neutrophil counts) and cholesterol levels are connected to muscle health. Previous studies have shown that inflammation increases with age and contributes to muscle loss. This study suggests that the balance between these two factors—inflammation and protective cholesterol—might be particularly important. However, this is one of the first studies specifically looking at this particular ratio and sarcopenia.

This study has important limitations. Because it’s a snapshot in time, we can’t prove the blood test causes muscle loss—only that they’re connected. People with certain health conditions might have been more likely to get blood tests, which could skew results. The study also relied on how sarcopenia was diagnosed at one point in time, which might not capture people in early stages. Finally, the findings come from U.S. health data, so they might not apply equally to other countries or populations.

The Bottom Line

At this stage, this research is interesting but not ready for clinical use. Current recommendations for preventing muscle loss remain: do strength training exercises 2-3 times per week, eat enough protein (especially important for older adults), and stay physically active. If you’re concerned about muscle loss, talk to your doctor about these proven strategies. Don’t ask for this specific blood test yet—it’s not standard practice.

This research is most relevant to older adults concerned about muscle loss, people with high cholesterol or inflammation markers, and healthcare providers looking for better ways to identify at-risk patients early. It’s less immediately relevant to younger, healthy people. If you have a family history of sarcopenia or are experiencing unexplained weakness, this research suggests talking to your doctor about preventive strategies.

If this blood test eventually becomes a clinical tool, benefits from acting on it would depend on what you do with the information. Strength training typically shows results in 4-8 weeks, with significant improvements in 3-6 months. However, this research is still in early stages—it will likely take several years of additional studies before doctors routinely use this test in practice.

Want to Apply This Research?

  • Track weekly strength training sessions (target: 2-3 sessions per week) and daily protein intake in grams. Note any changes in strength or muscle tone monthly. If you have access to your blood work, log your neutrophil and HDL cholesterol values when available to monitor trends.
  • Set a goal to add or increase strength training to 2-3 sessions weekly, focusing on major muscle groups. Use the app to log workouts and track protein intake (aim for 1.0-1.2 grams per kilogram of body weight daily, especially if over 65). Set reminders for consistent exercise timing.
  • Monthly: assess strength improvements through simple tests (how many push-ups, squats, or time to stand from a chair). Quarterly: review trends in workout consistency and protein intake. Annually: discuss blood work results with your doctor and compare neutrophil and HDL levels to track inflammation and cholesterol patterns over time.

This research is observational and cannot prove cause-and-effect relationships. The neutrophil-to-HDL ratio is not currently a standard clinical diagnostic tool for sarcopenia. Do not request this specific test from your doctor based on this study alone. If you’re concerned about muscle loss, weakness, or age-related changes in strength, consult your healthcare provider about appropriate evaluation and evidence-based interventions like resistance exercise and adequate protein intake. This information is for educational purposes and should not replace professional medical advice.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Relationship of the neutrophil-to-high-density lipoprotein cholesterol ratio with sarcopenia: A cross-sectional study.The Journal of international medical research (2025). PubMed 40906997 | DOI